MOOG INC. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that MOOG INC. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 27, 2025 | $3.86B | Nov 26, 2025 |
| FY2025 | Jun 28, 2025 | $969.58M | Nov 26, 2025 |
| FY2025 | Mar 29, 2025 | $934.02M | Nov 26, 2025 |
| FY2025 | Dec 28, 2024 | $907.88M | Nov 26, 2025 |
| FY2025 | Sep 28, 2024 | $3.61B | Nov 26, 2025 |
| FY2025 | Jun 29, 2024 | $914.14M | Nov 26, 2025 |
| FY2025 | Mar 30, 2024 | $920.21M | Nov 26, 2025 |
| FY2025 | Dec 30, 2023 | $855.22M | Nov 26, 2025 |
| FY2025 | Sep 30, 2023 | $3.32B | Nov 26, 2025 |
| FY2024 | Oct 1, 2022 | $3.04B | Nov 27, 2024 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Sep 30, 2017 | $649.27M | Nov 14, 2017 |
| FY2017 | Jul 1, 2017 | $626.18M | Nov 14, 2017 |
| FY2017 | Apr 1, 2017 | $632.40M | Nov 14, 2017 |
| FY2017 | Dec 31, 2016 | $589.67M | Nov 14, 2017 |
| FY2017 | Oct 1, 2016 | $619.08M | Nov 14, 2017 |
| FY2017 | Jul 2, 2016 | $613.26M | Nov 14, 2017 |
| FY2017 | Apr 2, 2016 | $611.14M | Nov 14, 2017 |
| FY2017 | Jan 2, 2016 | $568.46M | Nov 14, 2017 |
| FY2016 | Oct 3, 2015 | $623.22M | Nov 15, 2016 |
| FY2016 | Jul 4, 2015 | $634.54M | Nov 15, 2016 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 27, 2025 | $1.06B | Nov 26, 2025 |
| FY2025 | Jun 28, 2025 | $266.83M | Nov 26, 2025 |
| FY2025 | Mar 29, 2025 | $256.62M | Nov 26, 2025 |
| FY2025 | Dec 28, 2024 | $245.08M | Nov 26, 2025 |
| FY2025 | Sep 28, 2024 | $1.01B | Nov 26, 2025 |
| FY2025 | Jun 29, 2024 | $255.66M | Nov 26, 2025 |
| FY2025 | Mar 30, 2024 | $258.83M | Nov 26, 2025 |
| FY2025 | Dec 30, 2023 | $241.43M | Nov 26, 2025 |
| FY2025 | Sep 30, 2023 | $897.76M | Nov 26, 2025 |
| FY2024 | Oct 1, 2022 | $820.80M | Nov 27, 2024 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 27, 2025 | $235.03M | Nov 26, 2025 |
| FY2025 | Jun 28, 2025 | $58.49M | Nov 26, 2025 |
| FY2025 | Mar 29, 2025 | $54.61M | Nov 26, 2025 |
| FY2025 | Dec 28, 2024 | $57.53M | Nov 26, 2025 |
| FY2025 | Sep 28, 2024 | $208.79M | Nov 26, 2025 |
| FY2025 | Jun 29, 2024 | $59.11M | Nov 26, 2025 |
| FY2025 | Mar 30, 2024 | $54.51M | Nov 26, 2025 |
| FY2025 | Dec 30, 2023 | $52.64M | Nov 26, 2025 |
| FY2025 | Sep 30, 2023 | $175.16M | Nov 26, 2025 |
| FY2024 | Oct 1, 2022 | $155.18M | Nov 27, 2024 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 27, 2025 | $449.61M | Nov 26, 2025 |
| FY2025 | Sep 28, 2024 | $404.47M | Nov 26, 2025 |
| FY2025 | Sep 30, 2023 | $344.04M | Nov 26, 2025 |
| FY2024 | Oct 1, 2022 | $282.85M | Nov 27, 2024 |
| FY2023 | Oct 2, 2021 | $270.96M | Nov 14, 2023 |
| FY2022 | Oct 3, 2020 | $216.36M | Nov 14, 2022 |
| FY2021 | Sep 28, 2019 | $321.14M | Nov 15, 2021 |
| FY2020 | Sep 29, 2018 | $262.35M | Nov 17, 2020 |
| FY2019 | Sep 30, 2017 | $258.85M | Nov 12, 2019 |
| FY2018 | Oct 1, 2016 | $238.24M | Nov 13, 2018 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 27, 2025 | $93.67M | Nov 26, 2025 |
| FY2025 | Jun 28, 2025 | $21.91M | Nov 26, 2025 |
| FY2025 | Mar 29, 2025 | $24.48M | Nov 26, 2025 |
| FY2025 | Dec 28, 2024 | $23.61M | Nov 26, 2025 |
| FY2025 | Sep 28, 2024 | $112.77M | Nov 26, 2025 |
| FY2025 | Jun 29, 2024 | $27.79M | Nov 26, 2025 |
| FY2025 | Mar 30, 2024 | $28.38M | Nov 26, 2025 |
| FY2025 | Dec 30, 2023 | $30.58M | Nov 26, 2025 |
| FY2025 | Sep 30, 2023 | $106.55M | Nov 26, 2025 |
| FY2024 | Oct 1, 2022 | $109.53M | Nov 27, 2024 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 27, 2025 | $553.97M | Nov 26, 2025 |
| FY2025 | Jun 28, 2025 | $139.75M | Nov 26, 2025 |
| FY2025 | Mar 29, 2025 | $133.93M | Nov 26, 2025 |
| FY2025 | Dec 28, 2024 | $128.14M | Nov 26, 2025 |
| FY2025 | Sep 28, 2024 | $501.25M | Nov 26, 2025 |
| FY2025 | Jun 29, 2024 | $128.19M | Nov 26, 2025 |
| FY2025 | Mar 30, 2024 | $125.93M | Nov 26, 2025 |
| FY2025 | Dec 30, 2023 | $120.76M | Nov 26, 2025 |
| FY2025 | Sep 30, 2023 | $474.94M | Nov 26, 2025 |
| FY2024 | Oct 1, 2022 | $448.53M | Nov 27, 2024 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 27, 2025 | $273.09M | Nov 26, 2025 |
| FY2025 | Jun 28, 2025 | $32.40M | Nov 26, 2025 |
| FY2025 | Mar 29, 2025 | ($92.89M) | Nov 26, 2025 |
| FY2025 | Dec 28, 2024 | ($132.91M) | Nov 26, 2025 |
| FY2025 | Sep 28, 2024 | $197.86M | Nov 26, 2025 |
| FY2025 | Jun 29, 2024 | $50.40M | Nov 26, 2025 |
| FY2025 | Mar 30, 2024 | $19.14M | Nov 26, 2025 |
| FY2025 | Dec 30, 2023 | $61.92M | Nov 26, 2025 |
| FY2025 | Sep 30, 2023 | $139.65M | Nov 26, 2025 |
| FY2024 | Oct 1, 2022 | $246.80M | Nov 27, 2024 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 27, 2025 | $144.73M | Nov 26, 2025 |
| FY2025 | Jun 28, 2025 | $103.04M | Nov 26, 2025 |
| FY2025 | Mar 29, 2025 | $70.38M | Nov 26, 2025 |
| FY2025 | Dec 28, 2024 | $32.78M | Nov 26, 2025 |
| FY2025 | Sep 28, 2024 | $152.00M | Nov 26, 2025 |
| FY2025 | Jun 29, 2024 | $113.82M | Nov 26, 2025 |
| FY2025 | Mar 30, 2024 | $80.51M | Nov 26, 2025 |
| FY2025 | Dec 30, 2023 | $39.05M | Nov 26, 2025 |
| FY2025 | Sep 30, 2023 | $177.31M | Nov 26, 2025 |
| FY2024 | Oct 1, 2022 | $139.43M | Nov 27, 2024 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 27, 2025 | $4.43B | Nov 26, 2025 |
| FY2025 | Jun 28, 2025 | $4.38B | Nov 26, 2025 |
| FY2025 | Mar 29, 2025 | $4.31B | Nov 26, 2025 |
| FY2025 | Dec 28, 2024 | $4.18B | Nov 26, 2025 |
| FY2025 | Sep 28, 2024 | $4.08B | Nov 26, 2025 |
| FY2025 | Jun 29, 2024 | $4.08B | Nov 26, 2025 |
| FY2025 | Mar 30, 2024 | $4.04B | Nov 26, 2025 |
| FY2025 | Dec 30, 2023 | $3.98B | Nov 26, 2025 |
| FY2025 | Sep 30, 2023 | $3.77B | Nov 26, 2025 |
| FY2024 | Oct 1, 2022 | $3.43B | Nov 27, 2024 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 27, 2025 | $2.43B | Nov 26, 2025 |
| FY2025 | Jun 28, 2025 | $2.47B | Nov 26, 2025 |
| FY2025 | Mar 29, 2025 | $2.50B | Nov 26, 2025 |
| FY2025 | Dec 28, 2024 | $2.40B | Nov 26, 2025 |
| FY2025 | Sep 28, 2024 | $2.25B | Nov 26, 2025 |
| FY2025 | Jun 29, 2024 | $2.32B | Nov 26, 2025 |
| FY2025 | Mar 30, 2024 | $2.32B | Nov 26, 2025 |
| FY2025 | Dec 30, 2023 | $2.30B | Nov 26, 2025 |
| FY2025 | Sep 30, 2023 | $2.17B | Nov 26, 2025 |
| FY2023 | Oct 1, 2022 | $2.00B | Nov 14, 2023 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 27, 2025 | $1.99B | Nov 26, 2025 |
| FY2025 | Jun 28, 2025 | $1.91B | Nov 26, 2025 |
| FY2025 | Mar 29, 2025 | $1.81B | Nov 26, 2025 |
| FY2025 | Dec 28, 2024 | $1.79B | Nov 26, 2025 |
| FY2025 | Sep 28, 2024 | $1.83B | Nov 26, 2025 |
| FY2025 | Jun 29, 2024 | $1.76B | Nov 26, 2025 |
| FY2025 | Mar 30, 2024 | $1.72B | Nov 26, 2025 |
| FY2025 | Dec 30, 2023 | $1.68B | Nov 26, 2025 |
| FY2025 | Sep 30, 2023 | $1.60B | Nov 26, 2025 |
| FY2024 | Oct 1, 2022 | $1.44B | Nov 27, 2024 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 27, 2025 | $842.31M | Nov 26, 2025 |
| FY2025 | Jun 28, 2025 | $802.09M | Nov 26, 2025 |
| FY2025 | Mar 29, 2025 | $825.42M | Nov 26, 2025 |
| FY2025 | Dec 28, 2024 | $818.50M | Nov 26, 2025 |
| FY2025 | Sep 28, 2024 | $833.76M | Nov 26, 2025 |
| FY2025 | Jun 29, 2024 | $827.32M | Nov 26, 2025 |
| FY2025 | Mar 30, 2024 | $828.47M | Nov 26, 2025 |
| FY2025 | Dec 30, 2023 | $833.41M | Nov 26, 2025 |
| FY2025 | Sep 30, 2023 | $821.30M | Nov 26, 2025 |
| FY2025 | Oct 1, 2022 | $805.32M | Nov 26, 2025 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 27, 2025 | $2.83B | Nov 26, 2025 |
| FY2025 | Jun 28, 2025 | $2.78B | Nov 26, 2025 |
| FY2025 | Mar 29, 2025 | $2.73B | Nov 26, 2025 |
| FY2025 | Dec 28, 2024 | $2.68B | Nov 26, 2025 |
| FY2025 | Sep 28, 2024 | $2.64B | Nov 26, 2025 |
| FY2025 | Jun 29, 2024 | $2.60B | Nov 26, 2025 |
| FY2025 | Mar 30, 2024 | $2.55B | Nov 26, 2025 |
| FY2025 | Dec 30, 2023 | $2.51B | Nov 26, 2025 |
| FY2025 | Sep 30, 2023 | $2.46B | Nov 26, 2025 |
| FY2023 | Oct 1, 2022 | $2.36B | Nov 14, 2023 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 27, 2025 | $62.01M | Nov 26, 2025 |
| FY2025 | Jun 28, 2025 | $58.19M | Nov 26, 2025 |
| FY2025 | Mar 29, 2025 | $62.12M | Nov 26, 2025 |
| FY2025 | Dec 28, 2024 | $73.45M | Nov 26, 2025 |
| FY2025 | Sep 28, 2024 | $61.69M | Nov 26, 2025 |
| FY2025 | Jun 29, 2024 | $50.57M | Nov 26, 2025 |
| FY2025 | Mar 30, 2024 | $59.07M | Nov 26, 2025 |
| FY2025 | Dec 30, 2023 | $126.40M | Nov 26, 2025 |
| FY2025 | Sep 30, 2023 | $68.96M | Nov 26, 2025 |
| FY2023 | Oct 1, 2022 | $101.99M | Nov 14, 2023 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2014 | Sep 27, 2014 | $770.38M | Nov 10, 2014 |
| FY2014 | Sep 28, 2013 | $604.07M | Nov 10, 2014 |
| FY2013 | Sep 29, 2012 | $673.85M | Nov 12, 2013 |
| FY2012 | Oct 1, 2011 | $716.16M | Nov 20, 2012 |
| FY2011 | Oct 2, 2010 | $762.73M | Nov 30, 2011 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 27, 2025 | 7 | Nov 26, 2025 |
| FY2025 | Jun 28, 2025 | 1 | Nov 26, 2025 |
| FY2025 | Mar 29, 2025 | 1 | Nov 26, 2025 |
| FY2025 | Dec 28, 2024 | 1 | Nov 26, 2025 |
| FY2025 | Sep 28, 2024 | 6 | Nov 26, 2025 |
| FY2025 | Jun 29, 2024 | 1 | Nov 26, 2025 |
| FY2025 | Mar 30, 2024 | 1 | Nov 26, 2025 |
| FY2025 | Dec 30, 2023 | 1 | Nov 26, 2025 |
| FY2025 | Sep 30, 2023 | 5 | Nov 26, 2025 |
| FY2024 | Oct 1, 2022 | 4 | Nov 27, 2024 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 27, 2025 | 7 | Nov 26, 2025 |
| FY2025 | Jun 28, 2025 | 1 | Nov 26, 2025 |
| FY2025 | Mar 29, 2025 | 1 | Nov 26, 2025 |
| FY2025 | Dec 28, 2024 | 1 | Nov 26, 2025 |
| FY2025 | Sep 28, 2024 | 6 | Nov 26, 2025 |
| FY2025 | Jun 29, 2024 | 1 | Nov 26, 2025 |
| FY2025 | Mar 30, 2024 | 1 | Nov 26, 2025 |
| FY2025 | Dec 30, 2023 | 1 | Nov 26, 2025 |
| FY2025 | Sep 30, 2023 | 5 | Nov 26, 2025 |
| FY2024 | Oct 1, 2022 | 4 | Nov 27, 2024 |